Top

Published in:

01-08-2019 | Interesting Image

¹⁸F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma

Authors: Riccardo Laudicella, Guido Davidzon, Shreyas Vasanawala, Sergio Baldari, Andrei Iagaru

Published in: Nuclear Medicine and Molecular Imaging | Issue 4/2019

Abstract

We described the clinical impact of ¹⁸F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma. We detailed the diagnostic imaging workup focusing our attention on the CT, MR, and ¹⁸F-FDG PET/MR different findings. In this case, ¹⁸F-FDG PET/MR imaging evaluation resulted not only effective but also altered staging and spared additional invasive procedures in the assessment of a metastatic urethral adenocarcinoma. Combining a highly sensitive PET with the increase tissue resolution of MR (PET/MR) may improve abdominal and pelvic lesion detection outperforming PET/CT for this indication.

Potter M, Newport E, Morten KJ. The Warburg effect: 80 years on. Biochem Soc Trans. 2016;44:1499–505.CrossRefPubMedPubMedCentral

Tagliabue L, Del Sole A. Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients. Eur J Intern Med. 2014;25:6–11.CrossRefPubMed

Ha HK, Koo PJ, Kim SJ. Diagnostic accuracy of F-18 FDG PET/CT for preoperative lymph node staging in newly diagnosed bladder cancer patients: a systematic review and meta-analysis. Oncology. 2018;95:31–8.CrossRefPubMed

Kitajima K, Yamamoto S, Fukushima K, et al. Update on advances in molecular PET in urological oncology. Jpn J Radiol. 2016;34:470–85.CrossRefPubMedPubMedCentral

Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53:845–55.CrossRefPubMed

Quick HH, von Gall C, Zeilinger M, et al. Integrated whole-body PET/MR hybrid imaging: clinical experience. Investig Radiol. 2013;48:280–9.CrossRef

Wehrl HF, Sauter AW, Divine MR, et al. Combined PET/MR: a technology becomes mature. J Nucl Med. 2015;56:165–8.CrossRefPubMed

Xin J, Ma Q, Guo Q, et al. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer. Eur J Radiol. 2016;85:751–9.CrossRefPubMed

Schwartz M, Gavane SC, Bou-Ayache J, et al. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study. Abdom Radiol (NY). 2018;43:3462–7.CrossRef

Title: 18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma
Authors: Riccardo Laudicella
Guido Davidzon
Shreyas Vasanawala
Sergio Baldari
Andrei Iagaru
Publication date: 01-08-2019
Publisher: Springer Berlin Heidelberg
Published in: Nuclear Medicine and Molecular Imaging / Issue 4/2019
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI: https://doi.org/10.1007/s13139-019-00597-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

¹⁸F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2019

The Correlation Between Tenosynovitis Pattern on Two-Phase Bone Scintigraphy and Clinical Manifestation in Patients with Suspected Rheumatoid Arthritis

Minimum Standardized Uptake Value from Quantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography for Evaluation of Femoral Head Viability in Patients with Femoral Neck Fracture

Utility of FDG-PET/CT for the Detection and Characterization of Sternal Wound Infection Following Sternotomy

Theranostics Based on Liposome: Looking Back and Forward

Treatment Response Assessment of Skeletal Metastases in Prostate Cancer with 18F-NaF PET/CT

Measurement of Tumor Pressure and Strategies of Imaging Tumor Pressure for Radioimmunotherapy